101 related articles for article (PubMed ID: 12209032)
21. Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis.
Kempta Lekpa F; Piette JC; Bastuji-Garin S; Kraus VB; Stabler TV; Poole AR; Marini-Portugal A; Chevalier X
Clin Exp Rheumatol; 2010; 28(4):553-5. PubMed ID: 20810035
[TBL] [Abstract][Full Text] [Related]
22. Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis.
Rosillo MA; Sánchez-Hidalgo M; Sánchez-Fidalgo S; Aparicio-Soto M; Villegas I; Alarcón-de-la-Lastra C
Eur J Nutr; 2016 Feb; 55(1):315-25. PubMed ID: 25665892
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
Urakami T; Manki A; Inoue T; Oda M; Tanaka H; Morishima T
J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
[TBL] [Abstract][Full Text] [Related]
24. Deformational behaviour of knee cartilage and changes in serum cartilage oligomeric matrix protein (COMP) after running and drop landing.
Niehoff A; Müller M; Brüggemann L; Savage T; Zaucke F; Eckstein F; Müller-Lung U; Brüggemann GP
Osteoarthritis Cartilage; 2011 Aug; 19(8):1003-10. PubMed ID: 21616158
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108
[TBL] [Abstract][Full Text] [Related]
26. Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis.
Joosten LA; Helsen MM; Saxne T; Heinegård D; van de Putte LB; van den Berg WB
Inflamm Res; 1999 Jan; 48(1):48-55. PubMed ID: 9987683
[TBL] [Abstract][Full Text] [Related]
27. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
Gilliam BE; Chauhan AK; Low JM; Moore TL
Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C
Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150
[TBL] [Abstract][Full Text] [Related]
29. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis.
Forslind K; Eberhardt K; Jonsson A; Saxne T
Br J Rheumatol; 1992 Sep; 31(9):593-8. PubMed ID: 1525624
[TBL] [Abstract][Full Text] [Related]
30. Cartilage oligomeric matrix protein/thrombospondin-5 (COMP/TSP-5) levels do not correlate to functional class in patients with rheumatoid arthritis.
Andrade FD; Bender AL; da Silveira IG; Stein H; von Mühlen CA; Staub HL
Clin Rheumatol; 2009 Dec; 28(12):1441-2. PubMed ID: 19727918
[No Abstract] [Full Text] [Related]
31. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
32. Increased serum levels of cartilage oligomeric matrix protein in patients with psoriasis vulgaris: a marker for unknown peripheral joint involvement?
Skoumal M; Haberhauer G; Fink A; Steiner A; Klingler A; Varga F; Klaushofer K
Clin Exp Rheumatol; 2008; 26(6):1087-90. PubMed ID: 19210875
[TBL] [Abstract][Full Text] [Related]
33. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
[TBL] [Abstract][Full Text] [Related]
34. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
35. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
Bjørnhart B; Juul A; Nielsen S; Zak M; Svenningsen P; Müller K
J Rheumatol; 2009 Aug; 36(8):1749-54. PubMed ID: 19605679
[TBL] [Abstract][Full Text] [Related]
36. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.
Andersson ML; Petersson IF; Karlsson KE; Jonsson EN; Månsson B; Heinegård D; Saxne T
Ann Rheum Dis; 2006 Nov; 65(11):1490-4. PubMed ID: 16707535
[TBL] [Abstract][Full Text] [Related]
37. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis.
Roth A; Mollenhauer J; Wagner A; Fuhrmann R; Straub A; Venbrocks RA; Petrow P; Bräuer R; Schubert H; Ozegowski J; Peschel G; Müller PJ; Kinne RW
Arthritis Res Ther; 2005; 7(3):R677-86. PubMed ID: 15899053
[TBL] [Abstract][Full Text] [Related]
38. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis.
Björk J; Kleinau S; Tengblad A; Smedegård G
Arthritis Rheum; 1989 Mar; 32(3):306-11. PubMed ID: 2564780
[TBL] [Abstract][Full Text] [Related]
40. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
